Should you buy National Australia Bank Ltd?

Here are 4 reasons why I think you shouldn't.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Australia Bank Ltd (ASX: NAB) has one of our country's most iconic brands and employs over 42,000 people globally. Yet, as a listed company in the stockmarket, it continues to underperform both the S&P/ASX 200 (ASX: XJO) (^AXJO) and its closest peers.

So is it an opportunity to bag-a-bargain or is there an important reason why investors should be avoiding this seemingly discounted blue-chip stock? Here are four reasons I think it should be avoided, for now.

1. Its shares are not cheap. By historical standards its current price-earnings (P/E) and price-book (P/B) ratios are above average. Currently its P/E ratio is 13 and P/B ratio is 1.83. Some banking analysts consider a P/B ratio of 0.5 as a good entry point.

2. It is the least profitable big bank. Compared to its peers, such as Australia and New Zealand Banking Group (ASX: ANZ), NAB has the highest cost to income ratio (currently 45.4%), lowest Net Interest Margin (currently 1.94%) and lowest return on equity (currently 14.6%). Although you could take a contrarian view of NAB's shares, its profitability has fallen since 2006 and doesn't appear likely to turnaround anytime soon.

3. It has £3.3 billion in UK property which is included in the bank's "run-off portfolio". It has been running down these loans for a number of years yet they are still weighing on earnings.

4. NAB will struggle to beat the market. Although, arguably, it has the potential for upside surprises, its high share price coupled with falling profitability make it a questionable long-term investment.

To buy or not

NAB shares appear cheap but for good reason. It lags its peers in almost every area and profitability continues to fall across a number of valuation metrics. Therefore, in my opinion, it's not a buy, even at current prices.

However it does deserve a spot on your watchlist because, despite its blemishes, it offers a strong dividend yield and if it can successfully rundown the remaining UK commercial loan portfolio over the next two to three years, or if its share price drops significantly, it'll be worth a second look.

But don't rest on your laurels! While you wait for NAB shares to drop, you could consider adding other high yielding growth stocks to your portfolio…

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »